NLS Pharmaceutics AG
NASDAQ:NLSP
NLS Pharmaceutics AG
NASDAQ:NLSP
Price:
0.1415 USD
2.09%
Market Closed
Updated:
May 10, 2024
Income Statement
Earnings Waterfall
NLS Pharmaceutics AG
NLS Pharmaceutics AG
|
Revenue
|
0
USD
|
|
Operating Expenses
|
-15.3m
USD
|
|
Operating Income
|
-15.3m
USD
|
|
Other Expenses
|
-193.3k
USD
|
|
Net Income
|
-15.5m
USD
|
Income Statement
NLS Pharmaceutics AG
NLS Pharmaceutics AG
Currency: USD
| Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||||
| Operating Expenses |
(4)
|
(5)
|
(2)
|
(7)
|
(12)
|
(16)
|
(15)
|
(15)
|
|
| Selling, General & Administrative |
(2)
|
(3)
|
(2)
|
(5)
|
(6)
|
(6)
|
(7)
|
(7)
|
|
| Research & Development |
(2)
|
(2)
|
(0)
|
(2)
|
(6)
|
(10)
|
(9)
|
(8)
|
|
| Operating Income |
(4)
N/A
|
(5)
-26%
|
(2)
+56%
|
(7)
-197%
|
(12)
-73%
|
(16)
-35%
|
(15)
+3%
|
(15)
+1%
|
|
| Pre-Tax Income | |||||||||
| Interest Income Expense |
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Non-Reccuring Items |
(0)
|
(0)
|
0
|
0
|
0
|
0
|
(1)
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
|
| Pre-Tax Income |
(5)
N/A
|
(7)
-23%
|
(3)
+57%
|
(7)
-161%
|
(12)
-60%
|
(16)
-34%
|
(17)
-3%
|
(15)
+6%
|
|
| Net Income | |||||||||
| Income from Continuing Operations |
(5)
|
(7)
|
(3)
|
(7)
|
(12)
|
(16)
|
(17)
|
(15)
|
|
| Net Income (Common) |
(5)
N/A
|
(7)
-23%
|
(3)
+57%
|
(7)
-161%
|
(12)
-60%
|
(16)
-34%
|
(17)
-3%
|
(15)
+6%
|
|
| EPS (Diluted) |
-0.46
N/A
|
-0.56
-22%
|
-0.24
+57%
|
-0.66
-175%
|
-1
-52%
|
-1
N/A
|
-0.84
+16%
|
-0.4
+52%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
